S&P 500   5,251.58 (+0.06%)
DOW   39,762.49 (+0.01%)
QQQ   444.24 (-0.13%)
AAPL   171.14 (-1.25%)
MSFT   420.29 (-0.27%)
META   486.02 (-1.59%)
GOOGL   150.58 (-0.19%)
AMZN   179.90 (+0.04%)
TSLA   177.35 (-1.38%)
NVDA   905.82 (+0.37%)
NIO   4.61 (-1.28%)
AMD   181.80 (+1.23%)
BABA   72.48 (+1.24%)
T   17.61 (+0.34%)
F   13.23 (+1.30%)
MU   118.03 (-0.93%)
CGC   9.83 (+2.93%)
GE   175.88 (-2.35%)
DIS   122.62 (+1.36%)
AMC   3.70 (-14.75%)
PFE   27.88 (+0.36%)
PYPL   67.61 (+1.56%)
XOM   115.74 (+0.67%)
S&P 500   5,251.58 (+0.06%)
DOW   39,762.49 (+0.01%)
QQQ   444.24 (-0.13%)
AAPL   171.14 (-1.25%)
MSFT   420.29 (-0.27%)
META   486.02 (-1.59%)
GOOGL   150.58 (-0.19%)
AMZN   179.90 (+0.04%)
TSLA   177.35 (-1.38%)
NVDA   905.82 (+0.37%)
NIO   4.61 (-1.28%)
AMD   181.80 (+1.23%)
BABA   72.48 (+1.24%)
T   17.61 (+0.34%)
F   13.23 (+1.30%)
MU   118.03 (-0.93%)
CGC   9.83 (+2.93%)
GE   175.88 (-2.35%)
DIS   122.62 (+1.36%)
AMC   3.70 (-14.75%)
PFE   27.88 (+0.36%)
PYPL   67.61 (+1.56%)
XOM   115.74 (+0.67%)
S&P 500   5,251.58 (+0.06%)
DOW   39,762.49 (+0.01%)
QQQ   444.24 (-0.13%)
AAPL   171.14 (-1.25%)
MSFT   420.29 (-0.27%)
META   486.02 (-1.59%)
GOOGL   150.58 (-0.19%)
AMZN   179.90 (+0.04%)
TSLA   177.35 (-1.38%)
NVDA   905.82 (+0.37%)
NIO   4.61 (-1.28%)
AMD   181.80 (+1.23%)
BABA   72.48 (+1.24%)
T   17.61 (+0.34%)
F   13.23 (+1.30%)
MU   118.03 (-0.93%)
CGC   9.83 (+2.93%)
GE   175.88 (-2.35%)
DIS   122.62 (+1.36%)
AMC   3.70 (-14.75%)
PFE   27.88 (+0.36%)
PYPL   67.61 (+1.56%)
XOM   115.74 (+0.67%)
S&P 500   5,251.58 (+0.06%)
DOW   39,762.49 (+0.01%)
QQQ   444.24 (-0.13%)
AAPL   171.14 (-1.25%)
MSFT   420.29 (-0.27%)
META   486.02 (-1.59%)
GOOGL   150.58 (-0.19%)
AMZN   179.90 (+0.04%)
TSLA   177.35 (-1.38%)
NVDA   905.82 (+0.37%)
NIO   4.61 (-1.28%)
AMD   181.80 (+1.23%)
BABA   72.48 (+1.24%)
T   17.61 (+0.34%)
F   13.23 (+1.30%)
MU   118.03 (-0.93%)
CGC   9.83 (+2.93%)
GE   175.88 (-2.35%)
DIS   122.62 (+1.36%)
AMC   3.70 (-14.75%)
PFE   27.88 (+0.36%)
PYPL   67.61 (+1.56%)
XOM   115.74 (+0.67%)
LON:ERGO

Ergomed (ERGO) Share Price, News & Analysis

GBX 1,346
0.00 (0.00%)
(As of 11/13/2023)
Today's Range
1,346
1,346
50-Day Range
1,346
1,346
52-Week Range
895
1,380
Volume
280,999 shs
Average Volume
346,578 shs
Market Capitalization
£701.00 million
P/E Ratio
4,641.38
Dividend Yield
N/A
Price Target
GBX 1,400
ERGO stock logo

About Ergomed Stock (LON:ERGO)

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

ERGO Stock Price History

ERGO Stock News Headlines

Icon PLC IJF
Green Mining Innovation: Neuer Chief Financing Officer
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Green Mining Innovation: New Chief Financing Officer
Invesco Ltd: Form 8.3 - Ergomed PLC
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Man Group PLC : Form 8.3 - Ergomed plc
Form 8.3 - Ergomed_PLC
Samson Rock Capital LLP - Form 8.3 - Ergomed Plc
Form 8.3 - ERGO LN
Ergomed Share Price Surges Over 14% on Takeover Announcement
Form 8.3 - Octopus Investments - Ergomed plc
See More Headlines
Receive ERGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ergomed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/18/2017
Today
3/28/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 1,400
High Stock Price Target
GBX 1,450
Low Stock Price Target
GBX 1,350
Potential Upside/Downside
+4.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
£15 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£152.09 million
Cash Flow
GBX 24.62 per share
Book Value
GBX 179 per share

Miscellaneous

Free Float
N/A
Market Cap
£701.00 million
Optionable
Not Optionable
Beta
0.79
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Miroslav Reljanovic (Age 64)
    Founder & Executive Chairman
    Comp: $964.3k
  • Mr. Michael William Spiteri (Age 62)
    Chief Transformation & Technology Officer
    Comp: $52.77k
  • Jonathan Andrew Curtain (Age 47)
    CFO & Executive Director
  • Dr. Michael Forstner
    Head of Risk Management & Pharmacoepidemiology
  • Ms. Sally Amanuel
    President of PrimeVigilance
  • Dr. Gordana Tonkovic
    President of Clinical Research
  • Ms. Ronel Steyn
    Senior Vice President of Global Development
  • Keith Byrne
    Senior Vice-President of Capital Markets & Strategy
  • Joanne Bletcher
    Company Secretary

ERGO Stock Analysis - Frequently Asked Questions

Should I buy or sell Ergomed stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ERGO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERGO, but not buy additional shares or sell existing shares.
View ERGO analyst ratings
or view top-rated stocks.

What is Ergomed's stock price target for 2024?

3 Wall Street analysts have issued twelve-month price objectives for Ergomed's stock. Their ERGO share price targets range from GBX 1,350 to GBX 1,450. On average, they predict the company's share price to reach GBX 1,400 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts price targets for ERGO
or view top-rated stocks among Wall Street analysts.

How have ERGO shares performed in 2024?

Ergomed's stock was trading at GBX 1,346 on January 1st, 2024. Since then, ERGO stock has increased by 0.0% and is now trading at GBX 1,346.
View the best growth stocks for 2024 here
.

How were Ergomed's earnings last quarter?

Ergomed plc (LON:ERGO) announced its quarterly earnings data on Monday, September, 18th. The company reported $1.20 earnings per share (EPS) for the quarter. The business earned $22.91 million during the quarter. Ergomed had a trailing twelve-month return on equity of 18.08% and a net margin of 9.87%.

What other stocks do shareholders of Ergomed own?
How do I buy shares of Ergomed?

Shares of ERGO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ERGO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners